ENZE KANGTAI
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research.
ENZE KANGTAI
Industry:
Biopharma Biotechnology Genetics Medical
Founded:
2017-06-01
Address:
Changping, Beijing, China
Country:
China
Website Url:
http://www.echobiotech.com
Total Employee:
101+
Status:
Active
Contact:
+86 010-69739599
Email Addresses:
[email protected]
Total Funding:
0
Similar Organizations
Bioneer
Bioneer is a biotech company that develops molecular biology products and technologies.
Investors List
Baidu Ventures
Baidu Ventures investment in Series A - Enze Kangtai
Tigeryeah Capital
Tigeryeah Capital investment in Series A - Enze Kangtai
Volcanics Venture
Volcanics Venture investment in Series A - Enze Kangtai
Official Site Inspections
http://www.echobiotech.com
- Host name: 182.92.171.183
- IP address: 182.92.171.183
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Enze Kangtai"
ECHO Biotech 2025 Company Profile: Valuation, …
ECHO Biotech General Information Description. Developer and Provider of scientific research services and drugs intended for exosomes technology and …See details»
Enze Kangtai - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +86 010-69739599 Echo Biotech is a biotech firm mainly engaged in the R&D and production of …See details»
Beijing Enze Kangtai Biological Technology (Echo Biotech)
The company specialises in the development of exosome technology and diagnostic products in the field of liquid biopsy. ... Find out more about Beijing Enze Kangtai Biological Technology …See details»
Echo Biotech - Products, Competitors, Financials, Employees ...
Echobiotech.com. Overview & Products; Financials; Founded Year 2017. Stage Series A - III | Alive. Total Raised $15.48M. Mosaic Score. The Mosaic Score is an algorithm that measures …See details»
北京恩泽康泰生物科技有限公司 | LinkedIn
恩泽康泰是北京恩泽康泰生物科技有限公司旗下品牌。北京恩泽康泰生物科技有限公司成立于2017年6月1日，位于北京农学院科技综合楼，专注于液体 ...See details»
Beijing Enze Kangtai Biological Technology Co., Ltd.
了解Beijing Enze Kangtai Biological Technology Co., Ltd. (北京恩泽康泰生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的1篇文献。See details»
Echo Biotech (恩泽康泰) - Tech in Asia
Echo Biotech (恩泽康泰) is an innovative biotechnology company, focusing on exosome technology research and clinical transformation.See details»
北京恩泽康泰生物科技有限公司 - 企查查
Jun 1, 2017 企查查为您提供北京恩泽康泰生物科技有限公司的最新工商信息、公司简介、公司地址、电话号码、招聘信息、信用信息、财务信息、法律诉讼等多维度详细信息查询，让您对北京恩泽康泰生物科技有限公司能够做到全面的了解！See details»
北京恩泽康泰生物科技有限公司2023春招公告 - NEFU
Mar 28, 2023 公司简介：北京恩泽康泰生物科技有限公司是致力于外泌体技术开发与临床转化的创新型高科技公司，目前累计获得多轮数亿元融资。公司业务分为两个板块，一方面以外泌体 …See details»
恩泽康泰-北京恩泽康泰生物科技有限公司-企业详情-Inv…
查看医药魔方InvestGO®数据库恩泽康泰的公司信息。恩泽康泰（北京恩泽康泰生物科技有限公司），公司简介：北京恩泽康泰生物科技有限公司成立于2017年6月，是一家创新型生物科技公司，专注于外泌体技术研究与临床转化，目前已经 …See details»
北京恩泽康泰生物科技有限公司 - 爱企查
简介： 1、基本情况 北京恩泽康泰生物科技有限公司是一家专精特新中小企业、科技型中小企业(2024)、高新技术企业(2023)，该公司成立于2017年06月01日，位于北京市大兴区中关村科技园区大兴生物医药产业基地宝参南街16号院2号1 …See details»
Echo Biotech Announces Close Of ￥100 Million Series A Financing …
(VCBeat) July. 30, 2021 -- Beijing Enze Kangtai Biotechnology Co., Ltd. ("Echo Biotech") announced the closing of a Series A financing of nearly 100 million yuan, led by Longmen …See details»
Echo Biotech Stock Price, Funding, Valuation, Revenue & Financial ...
Echobiotech.com. Overview & Products; Financials; Total Raised $15.48M. Investors Count 9. Funding, Valuation & Revenue. 4 Fundings. Echo Biotech has raised $15.48M over 4 rounds. …See details»
恩泽康泰_北京恩泽康泰生物科技有限公司_亿欧数据
亿欧数据为您提供北京恩泽康泰生物科技有限公司的主营业务、公司简介、企业官网、公司地址、招聘信息、财务信息、融资情况、团队信息、电话号码、招投标信息、专利等多维度详细信息 …See details»
Libo Zhao - 首席技术官 - Echobiotech | 领英 - 领英 (中国)
Chief Technology Officer at Echobiotech · 10 year experience in microfluidics. Education 2001-2005 Wuhan University, Electronic Science & Technology (B.Eng.) 2005-2010 Wuhan …See details»
Exosupur<sup>®</sup> 外泌体纯化kit-血浆/微量-恩泽康泰
Exosupur ® 外泌体纯化kit-细胞上清等. Exosupur ® 外泌体纯化kit-血浆/微量. Exosupur ® 外泌体纯化袖珍柱. Exosupur ® 细胞上清高倍浓缩试剂盒. ContrExo ® 293F外泌体参考品. …See details»
【融资】恩泽康泰（EchoBiotech）完成数千万元A++轮融资医药新 …
Mar 3, 2023 ⌈ByDrug医药新闻摘要⌋ 2023-03-03 17:34，微创投：致力于外泌体技术开发与临床转化的创新型高科技公司北京 恩泽康泰 生物科技有限公司（恩泽康泰， Echo Biotech ）完成数 …See details»
恩泽康泰 | 项目信息-36氪
北京恩泽康泰生物科技有限公司是致力于外泌体技术开发与临床转化的创新型高科技公司。恩泽康泰将十余年的外泌体基础研究与分子生物学、细胞生物学及生物信息学相结合，建立了外泌体 …See details»
恩泽康泰（Echo Biotech）完成数千万元A++轮融资 - 创投之家
Mar 3, 2023 致力于外泌体技术开发与临床转化的创新型高科技公司北京恩泽康泰生物科技有限公司（恩泽康泰，Echo Biotech）完成数千万元A++轮融资，本轮融资由中博聚力、延瑞投资共 …See details»
ECHO NYC - LinkedIn
ECHO is an organization to foster connections between (E)ntrepreneurs, (C)apital and Clinicians, and (H)ealthcare (O)perators in the biomedical community in the greater NYC area. Skip to …See details»